These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16354303)

  • 1. Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction.
    Moore RA; Derry S; McQuay HJ
    BMC Urol; 2005 Dec; 5():18. PubMed ID: 16354303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.
    Berner MM; Kriston L; Harms A
    Int J Impot Res; 2006; 18(3):229-35. PubMed ID: 16239897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus.
    Vardi M; Nini A
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002187. PubMed ID: 17253475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vardenafil: a review of its use in erectile dysfunction.
    Keating GM; Scott LJ
    Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
    World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U; Gleiter CH
    Eur J Med Res; 2002 Oct; 7(10):435-46. PubMed ID: 12435622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction.
    Kendirci M; Bivalacqua TJ; Hellstrom WJ
    Expert Opin Pharmacother; 2004 Apr; 5(4):923-32. PubMed ID: 15102574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.
    Pomara G; Morelli G; Pomara S; Taddei S; Ghiadoni L; Dinelli N; Travaglini F; Dicuio M; Mondaini N; Salvetti A; Selli C
    J Androl; 2004; 25(4):625-9. PubMed ID: 15223851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.
    Markou S; Perimenis P; Gyftopoulos K; Athanasopoulos A; Barbalias G
    Int J Impot Res; 2004 Dec; 16(6):470-8. PubMed ID: 15229625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erectile dysfunction. New drugs with special consideration of the PDE 5 inhibitors].
    Porst H
    Urologe A; 2004 Jul; 43(7):820-8. PubMed ID: 15197447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.
    Brock GB; McMahon CG; Chen KK; Costigan T; Shen W; Watkins V; Anglin G; Whitaker S
    J Urol; 2002 Oct; 168(4 Pt 1):1332-6. PubMed ID: 12352386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vardenafil: a new approach to the treatment of erectile dysfunction.
    Hellstrom WJ
    Curr Urol Rep; 2003 Dec; 4(6):479-87. PubMed ID: 14622502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How effective are PDE-5 inhibitors?].
    Jünemann KP
    Urologe A; 2003 Apr; 42(4):553-8. PubMed ID: 12715127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibitors in male sexual dysfunction.
    Kuthe A
    Curr Opin Urol; 2003 Sep; 13(5):405-10. PubMed ID: 12917517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
    Seftel AD; Wilson SK; Knapp PM; Shin J; Wang WC; Ahuja S
    J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of PDE5 inhibitors.
    Rashid A
    Clin Cornerstone; 2005; 7(1):47-56. PubMed ID: 16156423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
    Montorsi F; Corbin J; Phillips S
    J Sex Med; 2004 Nov; 1(3):322-36. PubMed ID: 16422964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.